Elme Communities (ELME) shares were down 23% in Thursday premarket activity after the company said in a regulatory filing that a buyer terminated its agreement to acquire the Riverside Apartments property in Alexandria, Virginia, ending the proposed $280 million transaction.

ARS Pharmaceuticals (SPRY) stock was down 20% after the company said no new commercial formulary additions or payer coverage decisions were issued for neffy in the July 1 cycle.

Boxlight (BOXL) shares were down 17%, following the previous session's 37% gain.

Passage Bio (PASG) stock was down 17% after the company entered into a definitive all-stock merger agreement with biotechnology company Remix Therapeutics.